Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 117 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

9%

10 trials in Phase 3/4

Results Transparency

7%

3 of 41 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

53Total
Not Applicable (30)
Early P 1 (1)
P 1 (2)
P 2 (10)
P 3 (2)
P 4 (8)

Trial Status

Recruiting41
Completed41
Unknown15
Not Yet Recruiting12
Active Not Recruiting5
Enrolling By Invitation2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 41 completed trials

Clinical Trials (117)

Showing 20 of 20 trials
NCT06238232Not ApplicableCompletedPrimary

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism: The GAPA Randomized Clinical Trial

NCT06457074Phase 4CompletedPrimary

Finerenone for Patients With Primary Aldosteronism (FAIRY)

NCT07673445Not ApplicableRecruitingPrimary

Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism

NCT07814105Not ApplicableNot Yet RecruitingPrimary

[11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study

NCT05765786RecruitingPrimary

Diagnosing Variable Primary Aldosteronism.

NCT07800858Not ApplicableNot Yet RecruitingPrimary

Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism

NCT07470983Phase 2RecruitingPrimary

A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism

NCT07796048Not ApplicableNot Yet RecruitingPrimary

Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism

NCT07727356Not ApplicableActive Not Recruiting

EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders

NCT05405101Not ApplicableActive Not RecruitingPrimary

Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA

NCT07700888CompletedPrimary

A Novel and Efficient Biochemical Screening Strategy for Glucocorticoid-Remediable Aldosteronism: Combined 1-mg Overnight Dexamethasone Suppression Test and Steroid Profile

NCT07700472Not ApplicableNot Yet RecruitingPrimary

Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma

NCT07691801RecruitingPrimary

Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

NCT07688928Not ApplicableRecruitingPrimary

Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism

NCT07646535Phase 2Not Yet RecruitingPrimary

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism

NCT07635134RecruitingPrimary

Study on the Diagnostic Cut-off Point of 24-hour Urinary Aldosterone Measured by Liquid Chromatography-Tandem Mass Spectrometry in the Diagnosis of Primary Aldosteronism in the Oral Sodium Loading Test

NCT07621458RecruitingPrimary

Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism

NCT05368090Not ApplicableRecruitingPrimary

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

NCT02756754Not ApplicableCompletedPrimary

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

NCT06955286RecruitingPrimary

Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion

Scroll to load more

Research Network

Activity Timeline